Safety and Feasibility of Ultrasound-Triggered Targeted Drug Delivery of Doxorubicin From Thermosensitive Liposomes in Liver Tumours (TARDOX): A Single-Centre, Open-Label, Phase 1 Trial

The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(18)30332-2
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Elsevier BV

Related search

Doxorubicin Encapsulated in Stealth Liposomes Conferred With Light-Triggered Drug Release

Biomaterials
Mechanics of MaterialsBiophysicsBiomaterialsBioengineeringCompositesNanoscienceNanotechnologyCeramics
2016English

Microbubbles in Ultrasound-Triggered Drug and Gene Delivery

Advanced Drug Delivery Reviews
Pharmaceutical Science
2008English

Drug and Gene Delivery by “Bubble Liposomes” and Ultrasound

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2007English

Triggered Radiosensitizer Delivery Using Thermosensitive Liposomes and Hyperthermia Improves Efficacy of Radiotherapy: An in Vitro Proof of Concept Study

PLoS ONE
Multidisciplinary
2018English

pH-sensitive Polymer-Caged Liposomes for Targeted Drug Delivery

Science-Business eXchange
2009English

Ultrasound-Mediated Targeted Drug Delivery in T-Cells

Biophysical Journal
Biophysics
2019English

A Multicenter, Open Label, Uncontrolled, Phase Ii Trial Evaluating Safety and Efficacy of Venetoclax, Atezolizumab Andobinutuzumab in Richter Transformation From CLL

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

A 1-Year Safety Study of Dulaglutide in Japanese Patients With Type 2 Diabetes on a Single Oral Hypoglycemic Agent: An Open-Label, Nonrandomized, Phase 3 Trial

Endocrine Journal
EndocrinologyMetabolismDiabetes
2015English

Adalimumab for Nail Psoriasis: Efficacy and Safety From the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial

SKIN The Journal of Cutaneous Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy